Paul A. Barsanti,Cheng Hu,Jeff Jin,Robert Keyes,Robert Kucejko,Xiaodong Lin,Yue Pan,Keith B. Pfister,Martin Sendzik,James Sutton,Lifeng Wan
申请号：
US13773052
公开号：
US08778951B2
申请日:
2013.02.21
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention provides a compound of formula (I):and pharmaceutically acceptable salts, enantiomers, stereoisomers, rotamers, tautomers, diastereomers, or racemates thereof. Also provided is a method of treating a disease or condition mediated by CDK9.
